部份中文ACETOKEEP 3G INJ处方资料（仅供参考）
药物分类名称
血液替代剂
名称
Acetonekeep 3G注（500 mL）
忌讳
患有高钾血症，少尿，艾迪生病，严重烧伤，超嗜酸性症状的患者[因为这种药物含有钾，可能会增加血钾水平]
高磷血症，低钙血症，甲状旁腺功能减退患者[由于该药含磷，可能会增加血清磷值]
低镁血症，甲状腺功能减退症患者[由于该药含镁，可能会升高血清镁水平]
指示或效果
指示或效果
口服摄入量不足或不足时补充水分和电解质的供应和维护。
用量和用量
通常，成人静脉内静脉内注射500至1000mL一次，对于儿童，200至500mL一次。 对于成人和儿童，施用率应为每小时0.5g / kg体重或更少的葡萄糖。
顺便说一句，应该根据年龄，症状，体重等增加或减少。
计算儿童维生素体积的一般方法如下。
但是，应考虑到年龄，症状，水分流失和病理状况后，确定每名患者输注的液体体积。
重量：10公斤日剂量：100毫升/公斤
体重：11〜20kg日剂量：1000mL + 50mL / kg×（体重-10kg）
体重：20kg以上日剂量：1500mL + 20mL / kg×（体重-20kg）
虽然该药物每1000mL含有200kcal的能量，但是由于该药物单独不能充分满足当天所需能量的量，所以仅对于不能通过手术口服手术的患者才能使用该药物。 使用一段时间。
已知当葡萄糖的施用率超过0.5g / kg /小时时，葡萄糖不能在体内使用，部分可能在尿液中排出。
认真管理
没有高钾血症的肾衰竭患者[酸碱平衡异常，电解质异常可能发生]
心力衰竭患者[体液量过多可引起心脏负荷]
由于阻塞性尿路疾病引起的尿量下降的患者[体液体积可能变得过大]
糖尿病患者[血糖升高，引起水分/电解质异常或加重]
http://www.info.pmda.go.jp/go/pack/3319562A1049_1_06/3319562A1049_1_06?view=body
Name of drug classification
Blood substitute agent
Sales name
Acetonekeep 3G Note (500 mL)
Contraindication
Patients with hyperkalemia, oliguria, Addison's disease, severe burns, hypernitremia [Because this drug contains potassium, it may raise serum potassium level. ]
Patients with hyperphosphatemia, hypocalcemia, hypoparathyroidism [Since this drug contains phosphorus, it may raise the serum phosphorus level. ]
Hypomagnesemia, hypothyroidism patients [Since this drug contains magnesium, it may raise serum magnesium level. ]
Indication or effect
Indication or effect
Supply and maintenance of moisture and electrolyte when oral intake is impossible or inadequate, supplementation of energy.
Dosage and dosage
Usually, adults are intravenously infused intravenously with 500 to 1000 mL once, for children, 200 to 500 mL once. The administration rate should be 0.5 g / kg body weight or less per hour as glucose for both adults and children.
Incidentally, it should be increased or decreased according to age, symptom, body weight and the like.
A general method for calculating maintenance fluid volume in children is as follows.
However, the volume of fluid to be infused for each patient should be determined after considering age, symptoms, water loss and pathology.
Weight: Up to 10 kg Daily dose: 100 mL / kg
Body weight: 11 - 20 kg Daily dose: 1,000 mL + 50 mL / kg × (body weight - 10 kg)
Body weight: 20 kg or more Daily dose: 1,500 mL + 20 mL / kg × (body weight - 20 kg)
Although this drug contains 200 kcal as energy amount per 1,000 mL, since this drug alone can not sufficiently satisfy the amount of energy required on the day, it is only with this drug for patients who can not take oral intraoperatively by surgery etc. Use for a short period of time.
It is known that when the administration rate exceeds 0.5 g / kg per hour as glucose, glucose may not be used in vivo and part may be excreted in the urine.
Careful Administration
Patients with kidney failure without hyperkalemia [abnormalities in acid-base equilibrium, electrolyte abnormalities may occur]
Patients with heart failure [Heart load may occur due to excess of body fluid]
Patients whose urine volume has decreased due to obstructive uropathy disease [body fluid volume may become excessive]
Patient with diabetes [Increase in blood glucose level, causing water / electrolyte abnormality or exacerbating]